» Articles » PMID: 39624845

Maslinic Acid Induces Autophagy and Ferroptosis Via Transcriptomic and Metabolomic Reprogramming in Prostate Cancer Cells

Overview
Journal Front Pharmacol
Date 2024 Dec 3
PMID 39624845
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer has the second highest incidence among male malignancies. Only a few studies exist on the inhibitory effects of maslinic acid (MA) on prostate cancer. Herein we found that MA inhibits prostate cancer cell proliferation by decreasing CDK2, CDK4, and CDK6 expression and concurrently increasing p27, Rb, p-Rb expression. Further, MA was observed to induce prostate cancer cell autophagy by increasing the expression of p53, p-p53, ULK1, Beclin1, Atg7, and Atg5 and the ratio of LC3-II/I and concurrently decreasing the expression of ERK1/2 and mTOR. In addition, MA induced RM-1 cell ferroptosis by regulating glutathione, glutamate, and oxidized glutathione concentrations, inhibiting activity, and downregulating GPX4 expression. Integrated metabolome and transcriptome analysis led to the identification of key pathways (e.g., pathways in cancer and glutathione metabolism). Real-time quantitative PCR confirmed that MA regulates the expression of , , and . , we demonstrated that 50 mg/kg MA significantly inhibited the growth of tumors established using RM-1 cells. To summarize, we report that MA inhibits prostate cancer cell growth both and by inducing autophagy and ferroptosis via transcriptomic and metabolomic reprogramming.

References
1.
Wang D, Tang S, Zhang Q . Maslinic acid suppresses the growth of human gastric cells by inducing apoptosis via inhibition of the interleukin-6 mediated Janus kinase/signal transducer and activator of transcription 3 signaling pathway. Oncol Lett. 2017; 13(6):4875-4881. PMC: 5453006. DOI: 10.3892/ol.2017.6073. View

2.
Yu L, Xie X, Cao X, Chen J, Chen G, Chen Y . The Anticancer Potential of Maslinic Acid and Its Derivatives: A Review. Drug Des Devel Ther. 2021; 15:3863-3879. PMC: 8437384. DOI: 10.2147/DDDT.S326328. View

3.
Dorff T, Blanchard M, Adkins L, Luebbert L, Leggett N, Shishido S . PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med. 2024; 30(6):1636-1644. PMC: 11186768. DOI: 10.1038/s41591-024-02979-8. View

4.
Yap W, Khoo K, Lim S, Yeo C, Lim Y . Proteomic analysis of the molecular response of Raji cells to maslinic acid treatment. Phytomedicine. 2011; 19(2):183-91. DOI: 10.1016/j.phymed.2011.08.058. View

5.
Li Q, Li Z, Liu C, Xu M, Li T, Wang Y . Maslinic Acid Ameliorates Myocardial Ischemia Reperfusion Injury-Induced Oxidative Stress via Activating Nrf2 and Inhibiting NF-[Formula: see text]B Pathways. Am J Chin Med. 2023; 51(4):929-951. DOI: 10.1142/S0192415X2350043X. View